KURA
NASDAQ · Biotechnology
Kura Oncology Inc
$8.26
-0.17 (-2.02%)
Open$8.43
Previous Close$8.43
Day High$8.60
Day Low$8.17
52W High$12.49
52W Low$5.41
Volume—
Avg Volume1.49M
Market Cap746.61M
P/E Ratio—
EPS$-2.48
SectorBiotechnology
Analyst Ratings
Strong Buy
21 analysts
Price Target
+455.9% upside
Current
$8.26
$8.26
Target
$45.92
$45.92
$25.11
$45.92 avg
$52.51
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 56.19M | 146.41M | 142.51M |
| Net Income | -181,423,607 | 21.31M | 25.50M |
| Profit Margin | -322.9% | 14.6% | 17.9% |
| EBITDA | -200,470,705 | 41.90M | 41.44M |
| Free Cash Flow | — | 24.20M | 22.28M |
| Rev Growth | — | -6.0% | +22.0% |
| Debt/Equity | 0.02 | 0.38 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |